The Cannabist Company, one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today it is launching the brand dreamt, in Maryland, with additional markets and products to follow in 2025. Earlier this year, the Company acquired the brand through its acquisition of the Ciencia Labs portfolio.
The dreamt brand stands out from other cannabis products because of its unique formulations, which include a precise ratio of THC to CBD, in addition to a variety of supplements including GABA, and valerian root.
“dreamt is a transformative product, and we couldn’t be more excited to bring these highly sought after products to our shelves. Everyone deserves a good night’s sleep to feel refreshed and be at their best,” said Jesse Channon, President, The Cannabist Company. “dreamt products will utilize our high-quality cannabis to make a positive impact in people’s daily lives, as we strive to bring innovation and excellence to our markets.”
“dreamt is the result of extensive formulation development. Our goal was to produce these products at our state-of-the-art facilities across multiple markets and provide our patients and customers with a consistent and reliable experience,” said Blake Brower, VP, National Operations, The Cannabist Company. “We’re proud of our ability to maximize our facility’s capabilities and supply these high-quality products in the most demanded product category.”
dreamt is now available as a 5mg THC, 2mg CBD, 1mg CBN gummy sold in a 20 pack, at Columbia Care Chevy Chase and gLeaf dispensaries in Maryland and across the Company’s wholesale channels. The brand will debut in additional markets and expand its product offering in 2025.
